GrayMatters Health

GrayMatters Health (GMH) is a health technology company [1][2] developing and marketing an interventional psychiatry suite powered by digital fMRI-informed biomarkers [2]. The company's product, Prism, is a self-neuromodulation platform that enables patients to learn to regulate brain activity associated with their mental health condition [2]. A growing community of psychiatry clinics across the United States has built Prism programs for personalized Depression and PTSD patient care [2]. According to LinkedIn, the company employs 32 people and operates in the mental health care industry [3].

Something wrong or missing? Send a correction. Fixed within 24 hours.